Search

Displaying results 9541 - 9550 of 10000 in total
  1. Drug

    TRTL-729

    go.drugbank.com/drugs/DB33923
    Experimental

    TRTL-729 is a small molecule drug. TRTL-729 is under investigation in clinical trial NCT07811063 (A Study to Test a Single Dose of a New Tablet Formulation of TRTL-729).

  2. Drug

    VTP-201227

    go.drugbank.com/drugs/DB05652
    Experimental

    VTP-201227 has a novel mechanism of action and is being developed as a topical agent for the treatment of psoriasis with potential extensions into other dermatological indications. … It is being developed by Vitae Pharmaceuticals.

  3. Drug

    Fianlimab

    go.drugbank.com/drugs/DB18858
    Investigational

    Fianlimab is under investigation in clinical trial NCT06190951 (A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-pd1 Alone in Adult Participants With Resectable Stage 3 or … 4 Melanoma).

    Synonyms: Anti-lag-3 monoclonal antibody regn3767
  4. Drug

    Alpha-galactosylceramide

    go.drugbank.com/drugs/DB12232
    Investigational

    KRN7000 has been used in trials studying the treatment of Lung Cancer, Chronic Hepatitis C, Hepatitis B, Chronic, Unspecified Adult Solid Tumor, Protocol Specific, and Prevention of GvHD in Patients With

    Synonyms: 1-O-(α-D-galactopyranosyl)-N-hexacosanoylphytosphingosine
  5. Drug

    KITE-585

    go.drugbank.com/drugs/DB17409
    Investigational

    KITE-585 is an autologous, fully-human anti-B cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T cell therapy. It is being investigated in the treatment of multiple myeloma.

  6. Drug

    ORP-101

    go.drugbank.com/drugs/DB16072
    Investigational

    ORP-101 is under investigation in clinical trial NCT04129619 (A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)).

  7. Drug

    Lorecivivint

    go.drugbank.com/drugs/DB14883
    Investigational

    Lorecivivint is under investigation in clinical trial NCT03246399 (A Study of the Safety, Tolerability, and Pharmacokinetics of SM04690 Injectable Suspension Following Single Intradiscal Injection in Subjects

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
  8. Drug

    2-chloroethyl-3-sarcosinamide-1-nitrosourea

    go.drugbank.com/drugs/DB11688
    Investigational

    2-chloroethyl-3-sarcosinamide-1-nitrosourea has been used in trials studying the treatment of Colorectal Cancer, Brain and Central Nervous System Tumors, and Unspecified Adult Solid Tumor, Protocol Specific

    Synonyms: 2-chloroethyl-3-sarcosinamide-1-nitrosourea, ACETAMIDE, 2-((((2-CHLOROETHYL)NITROSOAMINO)CARBONYL)METHYLAMINO)-
  9. Drug

    Nerve Growth Factor

    go.drugbank.com/drugs/DB12620
    Investigational

    Nerve Growth Factor has been used in trials studying the prevention and treatment of Mental Handicap, Alzheimer's Disease, Traumatic Brain Injury, Cerebral Palsy Children, and Delayed Speech Development

  10. Drug

    MX006

    go.drugbank.com/drugs/DB33934
    Experimental

    MX006 is a biologic drug. MX006 is under investigation in clinical trial NCT07807241 (A Study of MX006 in Patients With Advanced and/or Metastatic Tumors Known to Express B7-H3).